JUBLIA

This brand name is authorized in United States. It is also authorized in Canada, Hong Kong SAR China.

Active ingredients

The drug JUBLIA contains one active pharmaceutical ingredient (API):

1	Efinaconazole UNII J82SB7FXWB - EFINACONAZOLE
	Efinaconazole is an azole antifungal used for the topical treatment of onychomycosis.
	Read more about Efinaconazole

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
JUBLIA Solution	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
D01AC19		D Dermatologicals → D01 Antifungals for dermatological use → D01A Antifungals for topical use → D01AC Imidazole and triazole derivatives
Discover more medicines within D01AC19

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02413388
HK	Department of Health Drug Office	66407
US	FDA, National Drug Code	0187-5400